[Skip to Content]
[Skip to Content Landing]
Views 2,724
Citations 0
Clinical Trials Update
August 28, 2018

Automated Device Improves Glucose Control in Hospitalized Patients

JAMA. 2018;320(8):749. doi:10.1001/jama.2018.12042

Recent research has shown that a closed-loop insulin delivery system—also known as an artificial pancreas—controls glucose more effectively than standard subcutaneous insulin therapy during hospitalization.

The investigators randomly assigned 136 adults with type 2 diabetes who needed insulin to receive it with the automated system or via standard subcutaneous therapy for 15 days or until they were discharged.

First Page Preview View Large
First page PDF preview
First page PDF preview